Linnea Olsson
Senior Director, Clinical Operations Carrick Therapeutics
Linnea Olsson is Senior Director of Clinical Operations at Carrick Therapeutics, bringing more than 25 years of global clinical operations experience across biotechnology and oncology drug development. She has led the operational strategy and execution of Phase I–III clinical trials, including registrational studies, with expertise spanning clinical trial management, CRO oversight, decentralized clinical trials, and cross-functional leadership.
Prior to joining Carrick Therapeutics, Linena held clinical operations leadership roles at Bristol Myers Squibb, Mirati Therapeutics, and EMD Serono, where she drove global oncology programs and contributed to initiatives focused on decentralized trials, diversity in clinical research, and risk-based monitoring. She is passionate about advancing operational excellence and developing innovative strategies that improve trial delivery while enhancing patient access and engagement.
Seminars
- Reduce unnecessary complexity in trial design
- Balance scientific rigor with operational feasibility
- Create protocols that improve enrollment and retention without compromising objectives
